Recommended Pages at investor.furiex.com
Furiex Pharmaceuticals / Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan
investor.furiex.com — “Furiex Pharmaceuticals / Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan” View full resource at investor.furiex.com
Most Recently Shared on February 28, 2011 at 5:58 pm By:
Symposier Endocrino Health Site
Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies for Type 2 Diabetes in Japan. http://bit.ly/fAoxP7
